Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy

Archives of Neurology

Volumn 56, Issue 3, 1999, Pages 295-300

  Takano, Hiroki ^a   Koike, Ryoko ^a   Onodera, Osamu ^a   Sasaki, Ryogen ^b   Tsuji, Shoji ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ADRENOLEUKODYSTROPHY; ARTICLE; CLINICAL ARTICLE; FRAMESHIFT MUTATION; GENE DELETION; GENE DISRUPTION; GENE MUTATION; GENOTYPE; HUMAN; JAPAN; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

EID: 0033055565     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.3.295     Document Type: Article

References (58)

1. Blaw ME. Melanodermic type leukodystrophy (adrenoleukodystrophy). In: Vinken PJ. ed. Handbook of Clinical Neurology. Vol 10. New York. NY: American Elsevier; 1970:128-133.
2. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP Jr. Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol. 1975; 32:577-591.
3. Moser HW, Moser AB. Adrenoleukodystrophy (X-linked). In: Scriver CR, Beaudet AL. Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill Book Co; 1988;1511-1532.
4. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 1997;120:1485-1508.
5. Geel BMV, Assies J, Wanders RJA, Barth PG. X-linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry. 1997; 63:4-14.
6. Powers JM, Schaumburg HH, Gaffiney CL. Kluver-Bucy syndrome caused by adreno-leukodystrophy. Neurology. 1980;30:1231-1232.
7. Power JM, Liu Y, Moser AB, Moser HW. The inflammatory myelinopathy of adrenoleukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol. 1992;51:630-643.
8. Powers JM. Adreno-leukodystrophy (adreno-testiculo-leukomyeloneuropathic-complex). Clin Neuropathol. 1985;4:191-199.
9. Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison's disease: adult variant of adrenoleukodystrophy. J Neurol. 1976;213:237-250.
10. Griffin JW, Goren E, Schaumburg H, Engel K, Loriaux L. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. Neurology. 1977;27:1107-1113.
11. Aubourg P, Chaussain JL. Adrenoleukodystrophy presenting as Addison's disease in children and adults. Trends Endcrinol Metab. 1991;2:49-52.
12. O'Neil BP, Marmion LC, Feringa ER. The adrenoleukomyeloneuropathy complex; expression in four generations. Neurology. 1981;31:151-156.
13. Martin JJ, Dompas B, Ceuterick C, Jakobs K. Adrenoneuromelopathy and adrenoleukodystrophy in two brothers. Eur Neurol. 1980;19:281-287.
14. Elrington GM, Bateman DE, Jeffrey MJ, Lawton NF. Adrenoleukodystrophy: heterogeneity in two brothers. J Neurol Neurosurg Psychiatry. 1989;52:310-313.
15. Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodny E, Suzuki K, Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26:851-860.
16. Kawamura N, Moser AB, Moser HW, et al. High concentration of hexacosanoate in cultured skin fibloblast lipids from adrenoleukodystrophy patients. Biochem Biophys Res Commun. 1978;82:114-120.
17. Moser HW, Moser AB, Kawamura N, et al. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblast. Ann Neurol. 1980;7:542-549.
18. Moser HW, Moser AB, Frayer KK, et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acid. Neurology. 1981;31:1241-1246.
19. Tsuji S, Suzuki M, Ariga T, Sekine M, Kuriyama M, Miyatake T, Abnormality of long-chain fatty acid in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J Neurochem. 1981;36:1046-1049.
20. Lazo O, Contreras M, Bhushan A, Stanley W, Singh I. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignocerotl-CoA ligase deficiency. Arch Biochem Biophys. 1989;270:722-728.
21. Molzer B, Bernheimer H, Heller R, Toifl K, Vetterlein M. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes. Clin Chim Acta. 1982;125:299-305.
22. Wanders RJA, van Roermund CWT, van Wijland MJA, et al. Direct evidence that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Biochem Biophys Res Commun. 1988;152:618-624.
23. Tsuji S, Sano T, Ariga T, Miyatake T. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropahty (AMN). J Biochem. 1981;90:1233-1236.
24. Tsuji S, Ohono T, Miyatake T, Suzuki A, Yamakawa T. Fatty acid elongation activity in fibloblasts from patients with adrenoleukodystrophy (ALD). J Biochem. 1984;96:1241-1247.
25. Koike R, Tsuji S, Ohno T, Suzuki Y, Orii T, Miyatake T. Physiological significance of fatty acid elongation system in adrenoleukodystrophy. J Neurol Sci. 1991; 103:188-194.
26. Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361: 726-730.
27. Kamijo K, Taketani S, Yokota S, Osumi T, Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J Biol Chem. 1991;265:4534-4540.
28. Lombard-Platet G, Savary S, Sarde C-O, Mandel J-L, Chimni G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci U S A. 1996;93:1265-1269.
29. Shani N, Watkins PA, Valle D, PXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene. Proc Natl Acad Sci U S A. 1995; 92:6012-6016.
30. Mosser J, Lutz Y, Elisabeth S, et al. The gene responsible for adrenoleukodystrophy encoded a peroxisomal membrane protein. Hum Mol Genet. 1995;3:265-271.
31. Contreras M, Mosser J, Mandel J-L, Auborg P, Singh I. The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett. 1994;344:211-215.
32. Kobayashi T, Yamada T, Yasulake T, Shinnoh N, Goto I, Iwaki T. Adrenoleukodystrophy gene encodes an 80 kDa membrane protein. Biochem Biophys Res Commun. 1994;201:1029-1034.
33. Kok F, Neuman S, Sarde CO, et al. Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum Mutat. 1995;6:104-115.
34. Koike R, Onodera O, Tabe H, et al. Partial deletion of putative adrenoleukodystrophy (ALD) gene in Japanese ALD patients. Hum Mutat. 1995;6:263-267.
35. Ligtenberg MJL, Kemp S, Sarde CO, et al. Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am J Hum Genet. 1995;56:44-50.
36. Kemp S, Ligtenberg MJL, van Geel BM, et al. Two intronic mutations in the adrenoleukodystrophy gene. Hum Mutat. 1995;6:272-273.
37. Krasemann EW, Meier V, Korenke GC, Hunneman DH, Hanefeld F. Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/ adrenomyeloneuropathy. Hum Genet. 1996;97:194-197.
38. Vorgerd M, Fuchs S, Tegenthoff M, Malin J-P. A missense point mutation (Ser515Phe) in the adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and genetic study. J Neurol Neurosurg Psychiatry. 1995;58:229-231.
39. Barcelo A, Giros M, Sarde CO, et al. De novo missense mutation Y174S in exon 1 of the adrenoleukodystrophy (ALD) gene. Hum Genet. 1995;95:235-237.
40. Barcelo A, Giros M, Sarde CO, et al. Identification of a new frameshift mutation (1801delAG) in the ALD gene. Hum Mol Genet. 1994;3:1889-1890.
41. Kemp S, Ligtenberg JL, van Geel BM, et al. Identification of a two base pair deletion in five unrelated families with adrenoleukodystrophy: a possible hot spot for mutations. Biochem Biophys Res Commun. 1994;202:647-653.
42. Braun A, Ambach H, Kammerer S, et al. Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes. Am J Hum Genet. 1995;56:854-861.
43. Fuchs S, Sarde CO, Wedemann H, Schwinger E, Mandel J-L. Gal A. Missense mutations are frequent in the gene for X-chromosomal adrenoleukodystrophy (ALD). Hum Mol Genet. 1994;3:1903-1905.
44. Berger J, Molzer B, Fae I, Bernheimer H. X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun. 1994;205:1638-1643.
45. Feigenbaum V, Lombard-Platet G, Guidoux S, Sarde CO, Mandel J-L, Aubourg P. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am J Hum Genet 1996;58:1135-1144.
46. Fanen P, Guodoux S, Sarde CO, Mandel J-L, Goossens M, Aoubourg P. Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J Clin Invest. 1994;94:516-520.
47. Cartier N, Sarde CO, Douar A-M, Mosser J, Mandel J-L, Aubourg P. Abnormal messenger RNA expression and a missense mutation in patients with X-linked adrenoleukodystrophy. Hum Mol Genet. 1993;2:1949-1951.
48. Song X-Q, Fukao T, Suzuki Y, et al. Identification of a novel frameshift mutation in a Japanese adrenoleukodystrophy patient. Hum Mol Genet. 1995;4:1093-1094.
49. Uchiyama A, Suzuki Y, Song X-Q, et al. Identification of a nonsense mutation in ALD protein cDNA from a patient with adrenoleukodystrophy. Biochem Biophys Res Commun. 1994;198:632-636.
50. Ueyama H, Yamano T, Shmada M, Ohkubo I. Novel missense and frameshift mutations in the adrenoleukodystrophy gene. Jpn J Hum Genet. 1996;41:407-411.
51. Yasutake T, Yamada H, Furuya H, Shinnoh N, Goto I, Kobayashi T. Molecular analysis of X-linked adrenoleukodystrophy patients. J Neurol Sci. 1995;131:58-64.
52. Matsumoto T, Kondoh T, Masuzaki H, et al. A point mutation at ATP-binding region of the ALD gene in a family with X-linked adrenoleukodystrophy. Jpn J Hum Genet. 1994;39:345-351.
53. Imamura A, Suzuki Y, Fukao T, et al. Two novel missense mutations in the ATP-binding domain of the adrenoleukodystrophy gene: immunoblotting and immunocytochemical study of two patients. Clin Genet. 1997;51:322-325.
54. Dodd A, Rowland SA, Hawkes SLJ, Kennedy MA, Love DR. Mutations in the adrenoleukodystrophy gene. Hum Mutat. 1997;9:500-511.
55. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18:5294-5299.
56. Onodera D, Oyake M, Takano H, Ikeuchi T, Igarashi S, Tsuji S. Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am J Hum Genet. 1995;57:1050-1060.
57. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-termination inhibitors. Proc Natl Acad Sci U S A. 1977;74:5463-5467.
58. Watkins PA, Gould SJ, Smith MA, et al. Altered expression of ALDP in X-linked adrenoleukodystrophy. Am J Hum Genet. 1995;57:292-301.